Logo image
Back
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function
Journal article   Peer reviewed

Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function

Gregory D. Borowski, Catherine D. Garofano, Leslie I. Rose, Scott R. Spielman, Heschi R. Rotmensch, Allan M. Greenspan and Leonard N. Horowitz
The American journal of medicine, v 78(3), pp 443-450
1985
DOI: https://doi.org/10.1016/0002-9343(85)90336-5
PMID: 3976702
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Both hyperthyroidism and hypothyroidism have been noted to occur in some patients treated with amiodarone for cardiac arrhythmias. To determine the frequency of the development of thyroidal abnormalities In patients receiving amiodarone, 45 euthyrold patients were prospectively evaluated. Serum samples were obtained for measurement of thyroxine, thyrotropin, trilodothyronine, and trilodothyronine resin uptake prior to initiation of amiodarone treatment and serially over a 12- to 27-month period during which amlodarone was administered. The patients were divided into four subgroups as follows: Group I (n = 22) had elevated thyroxine levels, Group IIA (n = 13) had normal thyroxine levels and normal thyrotropin levels, Group IIB (n = 7) had normal thyroxine levels and elevated thyrotropin levels, and Group III (n = 3) had subnormal thyroxine levels. Demographic factors (such as route of administration, cardiac diagnosis, sex of the patient, or indication for amiodarone therapy) and amiodarone levels had no significant effect on the thyroid hormone parameters. However, Group I patients were statistically older than the patients in the other groups. Linear regression analysis revealed a negative correlation for thyroxine levels and a positive correlation with thyrotropin levels with age for the whole group. The various groups were not statistically affected by duration of therapy, but a positive trend existed for increasing thyroxine levels. Although virtually all patients showed changes in their thyroid hormone levels, chemical hyperthyroldism (elevated thyroxine and trilodothyronine levels without symptoms) developed in only two patients (4 percent), and clinical hyperthyroidism (elevated thyroxine and trilodothyronine levels with symptoms) developed in no patients. Four patients (9 percent) became biochemically and clinically hypothyroid. Thus, amiodarone frequently influences thyroid hormonal parameters, but less commonly causes a change in actual thyroid function. However, hyperthyroidism and hypothyroidism do occur in a significant number of patients.

Metrics

8 Record Views
76 citations in Web of Science
67 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image